Review
Open access
Sep 2026
Targeting annexin A1 in kidney diseases: a novel therapeutic avenue
A mechanism-specific analysis of ANXA1 in kidney diseases identifies ANXA1 as a promising and druggable target for kidney diseases and evaluates current ANXA1-based agonists and inhibitors, linking molecular mechanisms to therapeutic potential.
Ju-Zhong Deng, Cang-Chun Liu, Ni Zeng et al.
· Renal Replacement Therapy · 0 citations